Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508204 · ClinicalTrials.gov registry record · Phase 1
Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects
A Phase 1 study, sponsored by Chinook Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT05508204 is a Phase 1 study that has completed, run by Chinook Therapeutics. The registered enrollment target is 36 participants.
The verdict
NCT05508204, a Phase 1 study, has completed, sponsored by Chinook Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
Phase 1, open-label study designed to evaluate safety, tolerability, pharmacokinetic, and pharmacodynamic of multiple doses of BION-1301 in Japanese healthy subjects.
Interventions
- DRUG BION-1301
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2022-12-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05508204
The ClinicalTrials.gov registry entry for NCT05508204 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chinook Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BION-1301 is the first listed.
NCT05508204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05508204 about?
NCT05508204 is a clinical study titled "Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects". Phase 1, open-label study designed to evaluate safety, tolerability, pharmacokinetic, and pharmacodynamic of multiple doses of BION-1301 in Japanese healthy subjects.
What is the current status of trial NCT05508204?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2022-07-19. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT05508204?
The interventions under investigation include: BION-1301 (DRUG).
Who is sponsoring clinical trial NCT05508204?
This trial is sponsored by Chinook Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.